Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

724 ARTÍCULOS , VIENDO DEL 676 AL 690

GBA1 Variants with Unknown Classification Are Modest Contributors to Parkinson's Disease Susceptibility

Parlar SC, Lee Y, Gan-Or Z.

Mov Disord. 2026 Mar;41(3):761-766. doi: 10.1002/mds.70127. Epub 2025 Nov 15.

Zolpidem in Parkinson's disease: An unexpected friend?

Mittal SO, Girigosavi KB.

Parkinsonism Relat Disord. 2026 Jan;142:108113. doi: 10.1016/j.parkreldis.2025.108113. Epub 2025 Nov 12.

Phenoconsonance: A New Form of Neurological Analysis That Complements Anatomical Localization and Disease Pattern Recognition

Guell X, Schmahmann JD.

J Neuropsychiatry Clin Neurosci. 2026 Spring;38(2):107-119. doi: 10.1176/appi.neuropsych.20250067. Epub 2025 Nov 17.

Mucuna pruriens in untreated Parkinson's disease in sub-Saharan Africa: A 12-month, multicenter, randomized, controlled trial

Cilia R, Cham M, Obese V, Akpalu A, Cereda E, Ame-Bruce E, Laryea R, Caronni S, Sarfo FS, Sorbo FD, Fahn S, Pezzoli G.

J Parkinsons Dis. 2026 Feb;16(1):99-109. doi: 10.1177/1877718X251383721. Epub 2025 Nov 21.

Nuclear Alpha-Synuclein: Mechanisms and Implications for Synucleinopathies

Outeiro TF, Koss DJ.

Mov Disord. 2026 Mar;41(3):603-612. doi: 10.1002/mds.70138. Epub 2025 Nov 26.

Practices, Resources and Challenges in Parkinson's Disease Management in Asia: Movement Disorders in Asia Study Group Report

Mohamed Ibrahim N, Phuenpathom W, Jagota P, Bhidayasiri R, Pal PK, Lin CH, Kukkle PL, Hatano T, Lim SY, Myrzayev Z, Shang H, Ong JN, Rosales RL, Youn J, Aldaajani Z, Mittal SO, Nawi AM, Ugawa Y.

Mov Disord Clin Pract. 2026 Feb;13(2):379-392. doi: 10.1002/mdc3.70447. Epub 2025 Nov 26.

Transforming Care Across Countries: Lessons from the Integrated Care Networks for Parkinson's Disease Study (iCARE-PD)

Dash D, Fabbri M, Saade J, van Munster M, Pedrosa D, Růžička E, Gal O, Ferreira JJ, Sánchez-Ferro Á, Lynch T, Eggers C, Singh A, Grimes D, Taljaard M, Rascol O, Mestre TA; and the iCARE‐PD consortium.

Mov Disord. 2026 Feb;41(2):445-454. doi: 10.1002/mds.70110. Epub 2025 Nov 27.

Effect on Dyskinesia of the Early Combination of Amantadine to Levodopa-Therapy in Parkinson's Disease: A Randomized, Placebo-Controlled Study (PREMANDYSK)

Rascol O, Ory-Magne F, Meissner WG, Maltête D, Defebvre L, Azulay JP, Thobois S, Houeto JL, Thalamas C, Sommet A, Geny C, Damier P, Anheim M, Marquès A, Viallet F, Giroud M, Lefaucheur R, Costentin G, Spampinato U, Samier-Foubert A, Carrière N, Mutez E, Mariani LL, Eusebio A, Prange S, Benatru I, Charif M, Brefel-Courbon C, Fabbri M, Galitzky M, Rousseau V, Saubion A, Catala H, Ferreira JJ, Burn DJ, Corvol JC; PREMANDYSK Study Group.

Mov Disord. 2026 Mar;41(3):729-740. doi: 10.1002/mds.70120. Epub 2025 Nov 29.

'What's in a Name?' Naming Genetically Determined Movement Disorders: Gap and Controversy

Marras C, Albanese A, Hallett M, Klein C, Lohmann K; Genetic Nomenclature in Movement Disorders Study Group Steering Committee; Jinnah HA.

Mov Disord. 2026 Feb;41(2):342-350. doi: 10.1002/mds.70143. Epub 2025 Nov 29.

Cerebrospinal Fluid Biomarkers of NLRP3 Pathway, Immune Dysregulation, and Neurodegeneration in Parkinson's Disease: A Meta-Analysis

Marinescu AM, Machado V, Pagano G, Muelhardt NM, Kustermann T, Mracsko EZ, Brockmann K, Shariati N, Anzures-Cabrera J, Zinnhardt B.

Mov Disord. 2026 Feb;41(2):466-477. doi: 10.1002/mds.70103. Epub 2025 Nov 29.

Reduced distress tolerance and elevated depression in functional tremor: A comparative cross-sectional observational study of tremor disorders

Sheehan P, Deng Y, Phelps HE, Jasinski N, Pyle K, Coleman MM, Sblendorio D, Talkington D, Murray A, Memon AA, Moreno-Escobar MC, Frey J.

J Psychosom Res. 2026 Feb;201:112479. doi: 10.1016/j.jpsychores.2025.112479. Epub 2025 Nov 29.

Primary Brain Calcification: An International Consensus on Nomenclature, Diagnosis, Evaluation, and Management

Luo W, Cen Z, Koek H, Carecchio M, Hozumi I, Chen WJ, Batla A, Balck A, Magrinelli F, Yang D, Cheng X, Westenberger A, Kakita A, Chen L, Lambert C, Liu JY, Keller A, Oliveira JRM, Xiong ZQ, Houlden H, Bhatia KP, Klein C, Nicolas G.

Mov Disord. 2026 Feb;41(2):315-336. doi: 10.1002/mds.70140. Epub 2025 Dec 4.

Dancing through time: Cognitive changes over six years of community dance in Parkinson's disease

Rooprai S, Dogra H, Karimi A, Rafique R, D'Alessandro E, Bearss K, Robichaud S, Bar RJ, DeSouza JF.

J Alzheimers Dis. 2026 Jan;109(1):400-411. doi: 10.1177/13872877251393640. Epub 2025 Dec 5.

LRRK2 as a Potential Disease-Modifying Target in Sporadic Parkinson's Disease

Lang AE, Hauser RA, Kalia LV, Hersh B, Berger Z, Arenas RL, Paisan-Ruiz C, Fraser K, Jennings D, Kluss JH, Huntwork-Rodriguez S, Henry AG, Greenamyre JT.

Mov Disord. 2026 Feb;41(2):297-314. doi: 10.1002/mds.70100. Epub 2025 Dec 12.

Reversing Autophagy Inhibition Ameliorates Neurodegeneration in Hereditary Spastic Paraplegia Caused by a Degradation-Resistant SPAST Mutation

Zhang D, Hu Y, Guo J, Wu D, Zhang Y, Yang L, Wang Y, Xiao N, Fan J, Dong Y, Zhong M, Liu T.

Mov Disord. 2026 Mar;41(3):625-637. doi: 10.1002/mds.70150. Epub 2025 Dec 17.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias